AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
| 2.06 Delayed Data As of 3:59pm ET |  -0.11 / -5.07%Today’s Change | 1.76 Today|||52-Week Range 9.60 | -8.85% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 377.0K | 613.0K | 265.0K | 941.0K | |
| Cost of Goods Sold | 733.0K | 1.1M | 902.0K | 1.4M | ||
| Depreciation And Amortization | 142.0K | 140.0K | 328.0K | 406.0K | ||
| Operating Expenses | Gross Income | -498.0K | -625.0K | -965.0K | -869.0K | |
| General Expenses | 8.8M | 10.4M | 11.4M | 12.5M | ||
| Research And Development | 3.6M | 2.7M | 1.4M | 1.2M | ||
| Total Operating Expenses | 9.7M | 11.6M | 12.6M | 14.3M | ||
| Non-Operating Expenses | Operating Income | -9.3M | -11.0M | -12.3M | -13.4M | |
| Extraordinary Credit | 0.00 | 23.0K | 23.0K | -- | ||
| Extraordinary Charge | -22.0K | 0.00 | -- | -98.0K | ||
| Interest Expense On Debt | 3.4M | 2.1M | 2.0M | 500.0K | ||
| Other Expenses | 334.0K | 472.0K | 604.0K | 554.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.5M | -12.6M | -13.7M | -12.4M | |
| Income Taxes | 0.00 | 0.00 | 0.00 | -3.0K | ||
| Net Income | -12.5M | -12.6M | -13.7M | -12.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 60.0M | 70.6M | 78.8M | 78.9M | |
| Shares To Calculate EPS Diluted | 60.0M | 70.6M | 78.8M | 78.9M | ||
| Earnings Per Share | EPS | -$0.21 | -$0.18 | -$0.17 | -$0.16 | |
| EPS Diluted | -$0.21 | -$0.18 | -$0.17 | -$0.16 | ||
